- THIS ARTICLE
- Full Text (Rapid PDF)
-
All Versions of this Article:
genetics.104.039958v1
170/2/919 most recent - Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Lin, M.
- Articles by Wu, R.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Lin, M.
- Articles by Wu, R.
doi:10.1534/genetics.104.039958
A more recent version of this article appeared on June 1, 2005.
REGULAR RESEARCH PAPERS |
Theoretical Basis for the Identification of Allelic Variants that Encode Drug Efficacy and Toxicity
Min Lin 1 and Rongling Wu 1*
1 University of Florida
* To whom correspondence should be addressed. E-mail: rwu{at}stat.ufl.edu.
Submitted on December 15, 2004
Revised on February 7, 2005
Accepted on 18 February 2005
Almost all drugs that produce a favorable response (efficacy) may also produce adverse effects (toxicity). The relative strengths of drug efficacy and toxicity that vary in human populations are controlled by the combined influences of multiple genes and environmental influences. In this article, we present a novel statistical model for sequence mapping of these two different but related drug responses. This model is incorporated by mathematical functions of drug response to varying doses and the statistical approaches for structuring the residual covariance matrix. We implement a closed-form solution for the EM algorithm to estimate the population genetic parameters of SNPs and the simplex algorithm to estimate the curve parameters that define the pharmacodynamic changes of different genetic variants and the antedependence parameters that model the covariance structure. Monte Carlo simulations were performed to investigate the statistical properties of our model. We discuss the implications of the model in pharmacogenetic and pharmacogenomic research.
Key Words: Drug response, EM algorithm, Emax model, HapMap, Sequence mapping